Chia Nan University of Pharmacy & Science Institutional Repository:Item 310902800/31085
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 18076/20274 (89%)
造访人次 : 5282950      在线人数 : 1425
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/31085


    標題: Glutamine in Alleviation of Radiation-Induced Severe Oral Mucositis: A Meta-Analysis
    作者: Leung, Henry W. C.
    Chan, Agnes L. F.
    貢獻者: China Med Univ, An Nan Hosp
    Chia Nan Univ Pharm & Sci, Dept Informat Management
    Chia Nan Univ Pharm, Dept Pharm
    關鍵字: placebo-controlled trial
    locally advanced head
    neck-cancer
    chemotherapy
    prevention
    chemoradiotherapy
    transplantation
    consequences
    malignancies
    management
    日期: 2016
    上傳時間: 2018-01-18 11:41:27 (UTC+8)
    出版者: Routledge Journals, Taylor & Francis Ltd
    摘要: The aim of this meta-analysis was to assess the effectiveness of glutamine to treat severe mucositis induced by radiation therapy in patients with head and neck cancer. We undertook electronic searches of PubMed (1990 to January 2015), Embase (1990 to January 2015), and the Cochrane Library (2013, Issue 2) to identify relevant studies. We included randomized controlled trials of glutamine to alleviate oral mucositis (OM) in patients with head and neck cancer who received radiotherapy. Information regarding methods, patients, results, and risk of bias was independently extracted by two authors. Statistical analyses were conducted to calculate the odds ratio and 95% confidence intervals (95%CIs) using fixed-effect models. We identified five clinical studies that included 234 patients with head and neck cancer. All studies were assessed as being at low risk of bias in most items of six domains. In this meta-analysis, glutamine treatment showed a statistically significant benefit with respect to reducing the risk and severity of OM induced by radiotherapy compared to either placebo or no treatment (risk ratio 0.17, 95%CI 0.06-0.47). Overall, glutamine significantly reduces the risk and severity of OM during radiotherapy or chemotherapy. Further prospective and large trials are required to support the findings.
    關聯: Nutrition and Cancer-An International Journal, v.68 n.5, pp.734-742
    显示于类别:[藥學系(所)] 期刊論文
    [資訊管理系] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    index.html0KbHTML1336检视/开启


    在CNU IR中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈